 
         
         
        
            
                For on-demand treatment of acute hereditary angioedema (HAE) attacks
                Be prepared for an HAE attack. Be prepared with BERINERT.
             
         
     
    
        
            BERINERT is the only on-demand treatment offering:
            
                
                       
                    Median onset of laryngeal 
attack relief: 15 minutes
                    Median onset of laryngeal attack relief: 15 minutes
                    
                 
                
                
                       
                    Single dose,
 rapid uptake*
                    
                 
                
                
                       
                    Approved use 
 in pediatrics†
                    
                 
                
                
                
                    
                        More than 50% of people with HAE may experience a laryngeal attack in their lifetime1 
                        
                     
                 
             
            
            
            
                Following self-administration of BERINERT for laryngeal HAE attacks, advise patients to immediately seek medical attention.
                
                    *
In a prospective, randomized, open-label, crossover study, 23 subjects with mild or moderate HAE received a single dose of BERINERT (1000 units) IV or SC during an attack-free interval.2
                 
                
                    †BERINERT is the only C1-INH approved for on-demand treatment of acute abdominal, facial or laryngeal attacks of HAE in adults and pediatric patients.
                
             
         
        
    
    
        
            
                
                
                    Get your patients started on BERINERT 
                    
                    Prescribe BERINERT and empower them to self-administer at the first sign 
                    of an HAE attack.
                     
                        Get started
                        
                    
                 
             
           
         
        
        
            
                
                    Have additional questions?
                    Connect with CSL Behring Medical Affairs to find additional information and ask questions.
                 
                
             
         
    
    
        
        
            
                
                    
                    HAE causes unpredictable and often painful attacks of swelling
                 
             
            
         
     
 
    
        References: 1. Zuraw BL. Clinical practice: hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036.
        2. Martinez-Saguer I, Cicardi M, Suffritti C, et al. Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study. Transfusion. 2014;54:1552-1561.
        3. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161(20):2417-2429.
        4. Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):264-274.